<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Ista Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 33-0511729
--------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
15279 Alton Parkway Building 100 Irvine, CA 92618
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
--------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK
--------------------------------------------------------------------------------
(Title of Class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
Incorporated by reference to Description of Capital Stock section and
Shares Eligible for Future Sale section on pages 49-53 of the
Registrant's Registration Statement on Form S-1 filed with the
Securities and Exchange Commission on April 5, 2000, (file number
333-34120) (the "S-1 Registration Statement").
Item 2. Exhibits
The following exhibits are filed as a part of this S-1 Registration
Statement:
*1. Incorporated by reference to Exhibits 1.1 through 27 to the S-1
Registration Statement.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: August 4, 2000 Ista Pharmaceuticals, Inc.
By: /s/ ISSAC J. VAUGHN
------------------------------------
Issac J. Vaughn
Assistant Secretary
